How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Broadcom enters 2026 at an inflection point, with strong tailwinds from its ASIC and Networking segments. Read why AVGO stock ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Shanda Group has entered a period of renewed visibility, with a series of incubated ventures coming to light over the past ...

Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...

Long-distance can be tough on any couple, but a gift can help bridge the gap, whether it's for a special occasion or simply a reminder that you're thinking of your significant other. We've rounded up ...

The Consequences of Exporting Nvidia’s H200 Chips to China Three CFR experts discuss President Donald Trump’s decision to allow Nvidia to sell advanced AI chip sales to China and what implications it ...

C compiler, LustreC, into a generator of both executable code and associated specification. Model-based design tools are ...

The relationship between cognition and emotion has fascinated Western philosophers for centuries. It is not surprising that much of that attraction has permeated brain science in general. Early ...

Kylie Jenner and Travis Scott end their on-again, off-again relationship in early January. (Meaning she’s fully single heading into 2023.) A source at the time tells Us Weekly, “Kylie and Travis are ...